We are live on ! Find out more
PHAT icon

Phathom Pharmaceuticals
PHAT

84 hedge funds and large institutions have $820M invested in Phathom Pharmaceuticals in 2021 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 22 increasing their positions, 23 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

63% more first-time investments, than exits

New positions opened: 13 | Existing positions closed: 8

6% more funds holding

Funds holding: 79 → 84 (+5)

1.91% more ownership

Funds ownership: 79.54% → 81.45% (+1.9%)

0% more funds holding in top 10

Funds holding in top 10: 6 → 6 (0)

3% less capital invested

Capital invested by funds: $843M → $820M (-$23.3M)

4% less repeat investments, than reductions

Existing positions increased: 22 | Existing positions reduced: 23

Holders
84
Holders Change
+5
Holders Change %
+6.33%
% of All Funds
1.47%
Holding in Top 10
6
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.11%
New
13
Increased
22
Reduced
23
Closed
8
Calls
$523K
Puts
–
Net Calls
+$523K
Net Calls Change
+$184K

Top Buyers

1
SG
StepStone Group
California
+$14M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$8.45M
3
GPP
Great Point Partners
Connecticut
+$7.34M
4
JP Morgan Chase
JP Morgan Chase
New York
+$5.21M
5
Fidelity Investments
Fidelity Investments
Massachusetts
+$5.12M

Top Sellers

1
Citadel Advisors
Citadel Advisors
Florida
-$2.03M
2
Ensign Peak Advisors
Ensign Peak Advisors
Utah
-$1.65M
3
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
-$1.47M
4
MWNA
Marshall Wace North America
New York
-$1.17M
5
Marshall Wace
Marshall Wace
United Kingdom
-$1.01M
Name Holding Trade Value Shares
Change 		Change in
Stake
TWM
76
Tradition Wealth Management
Minnesota
$11K – – –
EWA
77
Evolution Wealth Advisors
Florida
$4K -$5.78K -174 -60%
Simplex Trading
78
Simplex Trading
Illinois
$4K – – –
Bessemer Group
79
Bessemer Group
New Jersey
$3K – – –
US Bancorp
80
US Bancorp
Minnesota
$2K +$1.23K +37 +218%
NFSG
81
Newbridge Financial Services Group
Florida
$1K – – –
CAPTRUST Financial Advisors
82
CAPTRUST Financial Advisors
North Carolina
$1K +$831 +25 New
GA
83
Greenspring Associates
Maryland
– -$14.1M -415,277 Closed
MWNA
84
Marshall Wace North America
New York
– -$1.17M -34,436 Closed
Marshall Wace
85
Marshall Wace
United Kingdom
– -$1.01M -29,731 Closed
Cambridge Investment Research Advisors
86
Cambridge Investment Research Advisors
Iowa
– -$552K -16,300 Closed
EGM
87
Engineers Gate Manager
New York
– -$484K -14,310 Closed
Amundi
88
Amundi
France
– -$153K -4,513 Closed
LSA
89
Leonteq Securities AG
Switzerland
– -$50.8K -1,500 Closed
UBS Group
90
UBS Group
Switzerland
– -$24K -699 Closed
BCA
91
Berman Capital Advisors
Georgia
– +$299 +9 New
1 2 3
4

PHAT Hedge Fund Activity: Q3 2021 in Review

84 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Phathom Pharmaceuticals (PHAT) for Q3 2021, worth a combined $820M — down 2.8% from $843M a quarter earlier.

Buyers outnumbered sellers: 13 funds opened new PHAT positions and 8 closed out — a net gain of 5 holders — while 22 added to existing stakes and 23 trimmed.

The largest buyer was StepStone Group, opening a new position worth an estimated $14M. The largest seller was Citadel Advisors, cutting an estimated $2.03M.

  • 84 institutional investors held Phathom Pharmaceuticals (PHAT) as of Q3 2021, up from 79 in Q2 2021.
  • Funds reported $820M of Phathom Pharmaceuticals stock for Q3 2021, down 2.8% quarter-over-quarter.
  • 13 funds opened new Phathom Pharmaceuticals positions in Q3 2021 and 8 closed out, a net change of +5 holders.
  • The largest Phathom Pharmaceuticals buyer in Q3 2021 was StepStone Group, an estimated $14M added.
  • The largest Phathom Pharmaceuticals seller in Q3 2021 was Citadel Advisors, an estimated $2.03M sold.

Based on aggregated 13F filings for Q3 2021.